Hydatidiform Mole Market: What Published Estimates Mean
There is no single official “hydatidiform mole market size.” Public commercial-research pages use different disease scopes, base years and forecast periods. In November 2026, their headline estimates ranged from about USD 0.78 billion for gestational trophoblastic disease to USD 1.86 billion for a hydatidiform-mole-specific market. Those figures are not interchangeable and should not be treated […]
Continue Reading